Table of Contents
<< Previous Issue | Aug 2019 (Vol: 2019, Issue: 8) | Next Issue >> |
- Section: Licensing
-
Mallinckrodt Signs its First RNAi Deal with Silence Therapeutics
-
Celgene Restructures Jounce Alliance Amid BMS Acquisition
- Section: Mergers & Acquisitions
-
Pfizer Rescues Mylan with Upjohn Merger
-
Exact Sciences and Genomic Health to Merge in US$2.8 B Deal
- Section: Research & Development
-
Takeda Partners with Sosei Heptares on GPCR Targets
-
Bayer to Build Cell Therapy Pipeline with BlueRock Therapeutics Acquisition